PTSD - Post Traumatic Stress Disorder study: Intensive Treatment
Official title First-Line Intervention for PTSD - Intensive Treatment
ClinicalTrials.gov ID: NCT06700590
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if an intensive program can treat post-traumatic stress disorder (PTSD) in adults getting treatment for the first time, and whether it has lower societal costs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- PTSD diagnosis according to DSM-5 (CAPS-5);
- PTSD diagnosis stemming from 2 or more potentially traumatic events (PTEs)
- seeking first-time treatment for PTSD (or less than 8 sessions);
- employed (working or on sick leave for less than two years)
You likely can't join if
- Current psychotic disorder, severe alcohol or substance use disorder, high suicidal intent (MINI-S for DSM-5) and a concrete suicide plan, or severe...
- insufficient command of the Dutch language to be able to complete the assessments. This will be determined through clinical judgment at intake.
The study team makes the final eligibility decision.
Where it is enrolling
- Diemen, North Holland, Netherlands
- Haarlem, North Holland, Netherlands
- Groningen, Provincie Groningen, Netherlands
- Oegstgeest, South Holland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Diemen, North Holland, Netherlands; Haarlem, North Holland, Netherlands; Groningen, Provincie Groningen, Netherlands; Oegstgeest, South Holland, Netherlands. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.